Abstract
This study extends, into human systems, earlier work with mismatched analogues of polyinosinic acid-polycytidylic acid, rIn·rCn, which were consistently shown to be less toxic than rIn·rCn in various lower animal systems. We studied the mismatched analogues in a variety of human cells, hoping thereby to obtain an index of possible therapeutic efficacy and toxicity which might be observed in intact man. At doses which induce antiviral activity, the mismatched analogues of rIn·rCn, do not detrimentally affect various cell systems such as the cloning of human myeloid colony forming cells. With suspensions of human splenocytes, mismatched inducers are much less mitogenic than rIn·rCn, and the mismatched inducers show less effect on retarding the growth of human fibroblastic cells.
ACKNOWLEDGMENTS Dr. Leonard Schechtman carried out the experiments concerned with cell growth of the fibroblast cultures.
- Copyright © 1979 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|